Thomas J. Farley, PRINCIPAL ACCOUNTING OFFICER at Aditx Therapeutics, Inc. (ADTX), bought 2,500 shares at $2.68 ($7K) on 2021-05-26, disclosed to the SEC on 2021-05-27.
Open-market purchase of $7k ADTX by PRINCIPAL ACCOUNTING OFFICER. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.